Overview

An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunt

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

An open-label, single-dose, two-treatment, randomized, cross-over study to investigate the effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics and pharmacodynamics of acebutolol in healthy Korean and Japanese volunteers

Phase:

Phase 4

Details

Lead Sponsor:

In-Jin Jang, MD, PhD

Collaborators:

Kyushu University
Oita University
Seoul National University Hospital

Treatments:

Acebutolol